Insulins that meet patient needsOur new forms of insulin, based on novel protein designs and formulations, will enable insulin-dependent type 1 and type 2 diabetes patients to achieve improved glycemic control and quality of life, while reducing the costs of diabetes-related illnesses to the healthcare system. PIPELINE
|
New at Thermalin
Case Western Reserve's Michael Weiss gets nearly $1 million Helmsley grant for diabetes research
Case Western Reserve University receives Helmsley Trust grant to develop new glucose-sensitive insulin Breakthrough Article in Nature Substantiates Thermalin’s New Insulins Thermalin releases video on how new insulins will improve patient's lives Dr. Weiss and international team of researchers discover how insulin engages its primary binding site Thermalin Diabetes gets $4.5M NIH grant for next-generation insulin Thermalin Diabetes targets $8M series B investment, eyes clinical trials |
Get in touch
 |
 |
